Anna U. Loengard serves as Executive at CLOVER HEALTH INVESTMENTS, CORP. /DE, where they oversee executive responsibilities. Since joining the company, Anna U. Loengard has executed 14 insider transactions totaling $218.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 6, 2026 involved receiving (via award) 79,365 shares valued at $0.
Anna U. Loengard currently holds 527,456 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anna U. Loengard has been a net buyer of CLOV stock. They have purchased $218.7K and sold $0 worth of shares.
Anna U. Loengard's most recent insider trade was on Jan 6, 2026, when they sold 79,365 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.60 |
| Discretionary |
| Aug 13, 2025 | CLOV | $37.6K | Purchase | 14,500 | $2.59 | Discretionary |
| May 17, 2024 | CLOV | $9.3K | Purchase | 10,000 | $0.93 | Discretionary |
| May 16, 2024 | CLOV | $15.0K | Purchase | 15,600 | $0.96 | Discretionary |
| May 16, 2024 | CLOV | $1.4K | Purchase | 1,485 | $0.94 | Discretionary |
| Mar 14, 2024 | CLOV | $100.0K | Purchase | 137,000 | $0.73 | Discretionary |
| Mar 14, 2024 | CLOV | $9.9K | Purchase | 13,625 | $0.73 | Discretionary |
| Jan 3, 2024 | CLOV | $200.0K | Award | 206,185 | $0.97 | Discretionary |
| Sep 6, 2023 | CLOV | $13.0K | Purchase | 10,000 | $1.30 | Discretionary |
| Sep 6, 2023 | CLOV | $650 | Purchase | 500 | $1.30 | Discretionary |
| Sep 6, 2023 | CLOV | $650 | Purchase | 500 | $1.30 | Discretionary |
| Jan 3, 2023 | CLOV | $0 | Award | 176,991 | $N/A | Discretionary |
| Nov 28, 2022 | CLOV | $0 | Award | 12,665 | $N/A | Discretionary |